ソマティック・アクティベーションのBRAF変異によって引き起こされるリンパ系異常の表型の拡大
Michael D Fox1,2,3, Sumukh Kumar2, Allison D Britt2
1Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Pediatric blood & cancer
|August 30, 2025
まとめ
BRAF p.V600Eの変異は,拡散性異常や伝導の問題を含む複雑なリンパ異常を引き起こす. 患者に注意深くモニタリングし,慎重に手術を行うことが重要です.
科学分野:
- 遺伝学
- 血管の異常
- 皮膚科
背景:
- マクロキスティックリンパ性異常の原因として特定された体内BRAF (p.V600E) 変種.
- 最近の遺伝子プロファイリング研究で BRAFの変異は 複雑なリンパ異常と関連付けられています
- 以前の研究では,BRAF p.V600Eが特定のリンパ系不形成に起因することを明らかにした.
研究 の 目的:
- 血管異常における体質BRAF p.V600E変異の表型説明を拡大する.
- BRAF p.V600Eと複雑なリンパ系異常との関連を調査する.
- BRAF p.V600Eに関連する血管異常を有する個人の臨床表現を特徴付ける.
主な方法:
- 電子医療記録の遡及的検討
- 血管の異常と体内BRAF p.V600Eの変異がある人物のデータベース検索
- 複雑なリンパ系異常と特定されたBRAF変異の患者の分析
主要な成果:
- BRAF p.V600Eの変異体を持つ 複合リンパ系異常を患った6人の患者
- すべての患者は,拡散リンパ異常と異常リンパ伝導を示した.
- 誘導異常は手術後の5人の患者で,時には数年後に現れ,フェノタイプの異質性を示した.
結論:
- 複雑なリンパ異常は,BRAF p. V600E変異と関連した有意な表型を表します.
- BRAF p. V600Eに関連する異常を患っている患者には,縦断的な追跡と慎重な外科的アプローチが不可欠です.
- 伝導の問題を理解し,多学科的治療を導くためにさらなる研究が必要です.
関連する概念動画
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
The Ras Gene
6.4K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.4K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
Pleiotropy
41.1K
Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
41.1K
Cancers Originate from Somatic Mutations in a Single Cell
12.7K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.7K


